Xcout Intel
AI Proteins, Inc. competitors & alternatives
The 12 closest competitors and alternatives to AI Proteins, Inc. among protein therapeutics companies — ranked by similarity to what AI Proteins, Inc. actually does, not by market-cap band.
Subscribe to see AI Proteins, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About AI Proteins, Inc.
AI Proteins, Inc. is a growing biotechnology company based in Boston, Massachusetts, that aims to transform the development of oral biologic therapies for major diseases.
AI Proteins, Inc. at a glance
AI Proteins, Inc. is a protein therapeutics company headquartered in United States. It has raised at least $84.3M across the 5 funding rounds on record. Its most recent funding round raised $5M in March 2024. Xcout tracks 4 named people at AI Proteins, Inc., including James Bowman, PhD (Chief Technology Officer).
AI Proteins, Inc. leadership
- James Bowman, PhDChief Technology Officer
- Philip E. Brandish, PhDChief Scientific Officer
- Wendy DwyerChief Business Officer
- Chris BahlPresident, Chief Executive Officer, Founder
AI Proteins, Inc. funding rounds
At least $84.3M raised across the 5 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $5M | — | |
| SEC Form D filing | $8.3M | — | |
| — | $18.2M | 4 named | |
| SEC Form D filing | $11.3M | — | |
| Series A | $41.5M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 AI Proteins, Inc. competitors
Ranked by semantic similarity — how close each company is to AI Proteins, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
Biotech
Aikium is a biotechnology company headquartered in Berkeley, California, that integrates deep learning with ultra-large-scale wet lab experimentation to advance protein therapeutics.
Biotechnology
DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools, and automation to discover novel small molecules.
Health Tech
Protai Bio is an Israeli biotechnology company leveraging artificial intelligence and proteomics to advance drug discovery pipelines.
Healthcare
GRO Biosciences Inc. is an emerging biotechnology company headquartered in Cambridge, Massachusetts. The company leverages groundbreaking science to expand the amino acid alphabet and deliver on the promise of advanced protein therapeutics.
Biotechnology
Bonito Biosciences is a life-science company headquartered in Waltham, Massachusetts, building a delivery ligand discovery platform that combines encoded libraries, functional live-cell selections, and AI.
Animal Health
Animol Discovery, Inc. is a private biotechnology and drug discovery company founded in 2019. Headquartered in Boston, Massachusetts, the firm focuses on advancing pharmaceutical research and therapeutic development. It operates within the life sciences sector.
Healthcare
Ailomics Therapeutics, founded in 2022 and headquartered in Shanghai, China, is a therapeutics company focused on discovering novel targets.
Biotechnology
Superluminal Medicines is a generative biology and chemistry company headquartered in Boston, Massachusetts, focused on drug discovery and development.
Biotechnology
Boston Interactome, Inc. is a company that decodes the human protein interactome with the goal of developing safer and more targeted therapies. The company is currently in an early stage with more information coming soon.
Pharmaceuticals
Novilla Pharmaceuticals is a biotechnology company headquartered in Cambridge, Massachusetts, developing a novel class of localized medicines designed by AI to treat pain. The firm focuses on targeted therapeutics that function only where needed within the body. It operates as a privately held startup with a small scientific team.
Biotech
Launched in 2022 and headquartered in Seattle, Washington, Vilya is an AI peptide company co-founded by scientists from the Institute of Protein Design. The company uses artificial intelligence and synthetic biology to design novel macrocycle therapeutics inspired by nature.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of AI Proteins, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for AI Proteins, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →